LivaNova PLC Goodwill, Translation and Purchase Accounting Adjustments
LivaNova PLC (LIVN) reported Goodwill, Translation and Purchase Accounting Adjustments of -$13.70 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Notes › Goodwill and Other › Goodwill, Foreign Currency Translation and Measurement Period Adjustments
us-gaap:GoodwillTranslationAndPurchaseAccountingAdjustments · last filed 2026-08-05
- LivaNova PLC goodwill, translation and purchase accounting adjustments for the quarter ending 2026-06-30 was -$6.45M, a 120.49% decline year-over-year.
- LivaNova PLC goodwill, translation and purchase accounting adjustments for the quarter ending 2026-03-31 was -$7.25M, a 160.90% decline year-over-year.
- LivaNova PLC goodwill, translation and purchase accounting adjustments for the quarter ending 2025-09-30 was -$2.33M, a 115.35% decline year-over-year.
- LivaNova PLC goodwill, translation and purchase accounting adjustments for the quarter ending 2025-06-30 was $31.45M.
| Period end | Goodwill, Translation and Purchase Accounting Adjustments 3 month | Goodwill, Translation and Purchase Accounting Adjustments 6 month | Goodwill, Translation and Purchase Accounting Adjustments 8 month | Goodwill, Translation and Purchase Accounting Adjustments 9 month |
|---|---|---|---|---|
| 2026-06-30 | -$6.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$13.70M 10-Q · filed 2026-08-05 | ||
| 2026-03-31 | -$7.25M 10-Q · filed 2026-05-06 | |||
| 2025-09-30 | -$2.33M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $29.12M derived: sum of 2 quarters · filed 2025-11-05 | $41.03M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $31.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $43.36M 10-Q · filed 2025-08-06 | ||
| 2025-03-31 | $11.90M 10-Q · filed 2025-05-07 | |||
| 2024-09-30 | $15.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-31 | $9.74M derived: sum of 2 quarters · filed 2024-10-31 | -$1.39M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | -$5.45M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-01 | -$16.57M 10-Q · filed 2024-08-01 | ||
| 2024-03-31 | -$11.12M 10-Q · filed 2024-05-03 | |||
| 2023-09-30 | -$12.16M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-01 | -$7.39M derived: sum of 2 quarters · filed 2023-11-01 | -$1.73M 10-Q · filed 2023-11-01 | |
| 2023-06-30 | $4.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-26 | $10.43M 10-Q · filed 2023-07-26 | ||
| 2023-03-31 | $5.66M 10-Q · filed 2023-05-03 | |||
| 2022-09-30 | -$27.28M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-02 | -$51.70M derived: sum of 2 quarters · filed 2022-11-02 | -$54.63M 10-Q · filed 2022-11-02 | |
| 2022-06-30 | -$24.42M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-03 | -$27.35M 10-Q · filed 2022-08-03 | ||
| 2022-03-31 | -$2.93M 10-Q · filed 2022-05-04 | |||
| 2021-09-30 | -$13.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | -$4.84M derived: sum of 2 quarters · filed 2021-11-03 | -$17.16M 10-Q · filed 2021-11-03 | |
| 2021-06-30 | $8.28M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-07-28 | -$4.04M 10-Q · filed 2021-07-28 | ||
| 2021-03-31 | -$12.33M 10-Q · filed 2021-04-28 | |||
| 2020-09-30 | $16.27M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-10-29 | $29.91M derived: sum of 2 quarters · filed 2020-10-29 | $2.68M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $13.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-07-29 | -$13.59M 10-Q · filed 2020-07-29 | ||
| 2020-03-31 | -$27.22M 10-Q · filed 2020-04-30 | |||
| 2019-09-30 | -$16.17M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-10-30 | -$8.12M derived: sum of 2 quarters · filed 2019-10-30 | -$9.49M 10-Q · filed 2019-10-30 | |
| 2019-06-30 | $8.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-07-31 | $6.68M 10-Q · filed 2019-07-31 | ||
| 2019-03-31 | -$1.37M 10-Q · filed 2019-05-01 | |||
| 2018-09-30 | $809.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-01 | -$23.51M derived: sum of 2 quarters · filed 2018-11-01 | -$19.25M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | -$24.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-02 | -$20.06M 10-Q · filed 2018-08-02 | ||
| 2018-03-31 | $4.26M 10-Q · filed 2018-05-03 | |||
| 2017-09-30 | $17.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-02 | $46.94M 10-Q · filed 2017-11-02 | ||
| 2017-06-30 | $29.39M 10-Q · filed 2017-08-09 | |||
| 2016-09-30 | -$1.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | -$9.43M derived: sum of 2 quarters · filed 2016-11-02 | $9.76M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | -$8.06M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $11.13M 10-Q · filed 2016-08-05 | ||
| 2016-03-31 | $19.18M 10-Q · filed 2016-05-09 | |||
| 2015-12-31 | -$17.79M 10-KT · filed 2016-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |